SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-006576
Filing Date
2024-02-09
Accepted
2024-02-09 10:05:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20021128_sc13ga.htm SC 13G/A 54676
  Complete submission text file 0001140361-24-006576.txt   56556
Mailing Address 168 ROBINSON ROAD #37-01 CAPITAL TOWER SINGAPORE U0 068912
Business Address 168 ROBINSON ROAD #37-01 CAPITAL TOWER SINGAPORE U0 068912 065-6889-8888
GIC Private Ltd (Filed by) CIK: 0000936828 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88023 | Film No.: 24612697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)